Bitcoin drives $1.4B crypto fund surge
Crypto investment products recorded $1.4 billion in inflows last week, marking the second-strongest weekly total since January as rising Bitcoin prices boosted sentiment.

TV presenter and finance editor at Grafa, with a Master’s in Commerce from UWA and diverse industry experience in finance, insurance, and media.
Crypto investment products recorded $1.4 billion in inflows last week, marking the second-strongest weekly total since January as rising Bitcoin prices boosted sentiment.
Crypto advocacy group Coin Center said software code should be treated as protected speech under the First Amendment as developers face rising legal risks.
Coinbase has launched crypto-backed USDC loans in the United Kingdom, allowing users to borrow against Bitcoin, Ethereum and cbETH.
Deutsche Bank said U.S. crypto adoption rebounded to 12% in March from 7% in February, returning to levels last seen in mid-2025.
Binance’s top traders are steadily increasing long positions in Dogecoin despite muted price action, signalling growing bullish conviction among large market participants.
Challenger (ASX:CGF) demonstrated momentum in its third-quarter update, headlined by a 19% growth in total life sales, reaching $1.7 billion.
Yancoal Australia (ASX:YAL) has formalised contingency plans amid growing uncertainty regarding its diesel fuel security beyond May.
AGNC Investment (NASDAQ:AGNC) released its financial results for the first quarter ended March 31, 2026, revealing the impact of a persistent and volatile interest rate environment on the mortgage real estate investment trust (REIT) sector.
Dynex Capital (NYSE:DX), a real estate investment trust (REIT) specializing in high-quality mortgage assets, today released its financial results for the first quarter ended March 31, 2026.
Merck (NYSE:MRK), known as MSD outside the U.S. and Canada, announced today that the U.S. Food and Drug Administration (FDA) has granted priority review for two supplemental Biologics License Applications (sBLA) involving its anti-PD-1 therapy, Keytruda.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy